Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.
Yilmaz Y, Zeybel M, Adali G, Cosar AM, Sertesen E, Gokcan H, Bahcecioglu HI, Sahin M, Tulunay C, Ergun I, Turan I, Idilman IS, Celikel C, Kirimlioglu H, Akyol G, Yilmaz F, Sokmensuer C, Guveli H, Akarca US, Akyuz U, Genc V, Akyildiz M, Yazihan N, Tutar E, Ates F, Dincer D, Balaban Y, Kiyici M, Akdogan M, Sonsuz A, Idilman R; Members of Fatty Liver Special Interest Group; Yapali S, Dursun H, Aladag M, Satman I, Karcaaltincaba M, Arikan C, Gulerman F, Selimoglu A, Ozen H, Basaranoglu M, Karakan T, Yurci A, Demir K, Koruk M, Uygun A, Sezgin O, Gulec S, Besisik F, Simsek H, Hulagu S, Tozun N, Mardinoglu A, Demir M, Doganay L, Akarsu M, Karasu Z, Kaymakoglu S, Gunsar F. Yilmaz Y, et al. Among authors: adali g. Hepatol Forum. 2023 Mar 15;4(Suppl 1):1-32. doi: 10.14744/hf.2023.2023.0011. eCollection 2023. Hepatol Forum. 2023. PMID: 37920782 Free PMC article.
The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study.
Yilmaz Y, Yilmaz N, Ates F, Karakaya F, Gokcan H, Kaya E, Adali G, Caliskan Kartal A, Sen I, Ahishali E, Ozenirler S, Koruk M, Uygun A, Idilman R; Turkish Association for the Study of the Liver (TASL); Fatty Liver Diseases Special Interest Groups. Yilmaz Y, et al. Among authors: adali g. Hepatol Forum. 2021 May 21;2(2):37-42. doi: 10.14744/hf.2021.2020.0033. eCollection 2021 May. Hepatol Forum. 2021. PMID: 35783905 Free PMC article.
Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.
Akarsu M, Onem S, Turan I, Adali G, Akdogan M, Akyildiz M, Aladag M, Balaban Y, Danis N, Dayangac M, Gencdal G, Gokcan H, Sertesen E, Gurakar M, Harputluoglu M, Kabacam G, Karademir S, Kiyici M, Idilman R, Karasu Z. Akarsu M, et al. Among authors: adali g. Turk J Gastroenterol. 2021 Sep;32(9):712-719. doi: 10.5152/tjg.2021.21608. Turk J Gastroenterol. 2021. PMID: 34609299 Free PMC article.
Characteristics of patients with hepatocellular carcinoma: A multicenter study.
Guzelbulut F, Karaogullarindan U, Akkiz H, Altintas E, Demirtas CO, Bahadir O, Keklikkiran C, Yildirim AE, Gumussoy M, Balci HR, Gokcen P, Gokce DT, Simsek C, Turan I, Can G, Gokbulut V, Yaras S, Adali G, Akdogan RA, Avcioglu U, Demir M, Doganay HL, Vatansever S, Sumer H, Dilber F, Kayhan MA, Balaban HY, Simsek H, Ozdogan OC, Akarca US, Karasu Z, Gunsar F, Idilman R. Guzelbulut F, et al. Among authors: adali g. Hepatol Forum. 2022 Sep 23;3(3):71-76. doi: 10.14744/hf.2022.2022.0028. eCollection 2022 Sep. Hepatol Forum. 2022. PMID: 36177097 Free PMC article.
Portal vein thrombosis risk factors in liver transplant candidates.
Ak C, Adali G, Sayar S, Agackiran A, Kulali F, Kahraman R, Ozturk O, Ozdil K. Ak C, et al. Among authors: adali g. Hepatol Forum. 2022 Sep 23;3(3):88-92. doi: 10.14744/hf.2022.2022.0005. eCollection 2022 Sep. Hepatol Forum. 2022. PMID: 36177096 Free PMC article.
Global multi-stakeholder endorsement of the MAFLD definition.
Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Global multi-stakeholder consensus on the redefinition of fatty liver disease. Méndez-Sánchez N, et al. Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248211 Free article. No abstract available.
41 results